Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Deferred Taxes (2019 - 2025)

Historic Deferred Taxes for Health Catalyst (HCAT) over the last 7 years, with Q3 2025 value amounting to $43000.0.

  • Health Catalyst's Deferred Taxes rose 10806.75% to $43000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 19320.39%. This contributed to the annual value of $77000.0 for FY2024, which is 86250.0% up from last year.
  • As of Q3 2025, Health Catalyst's Deferred Taxes stood at $43000.0, which was up 10806.75% from -$224000.0 recorded in Q2 2025.
  • Health Catalyst's Deferred Taxes' 5-year high stood at $594000.0 during Q4 2024, with a 5-year trough of -$6.8 million in Q3 2021.
  • In the last 5 years, Health Catalyst's Deferred Taxes had a median value of $2000.0 in 2021 and averaged -$615052.6.
  • Per our database at Business Quant, Health Catalyst's Deferred Taxes crashed by 18000000.0% in 2022 and then skyrocketed by 2960000.0% in 2024.
  • Quarter analysis of 5 years shows Health Catalyst's Deferred Taxes stood at -$311000.0 in 2021, then surged by 101.29% to $4000.0 in 2022, then tumbled by 50.0% to $2000.0 in 2023, then surged by 29600.0% to $594000.0 in 2024, then crashed by 92.76% to $43000.0 in 2025.
  • Its Deferred Taxes was $43000.0 in Q3 2025, compared to -$224000.0 in Q2 2025 and $67000.0 in Q1 2025.